Castleark Management LLC Nektar Therapeutics Transaction History

Castleark Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 15, 2018	SELL	$46.25 - $104.45 $4.74 Million - $10.7 Million	-102,575 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $5.89 Million - $11.1 Million	102,575 New	102,575 $10.9 Million
Q4 2017 Feb 15, 2018	SELL	$23.02 - $60.5 $5.17 Million - $13.6 Million	-224,764 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$17.79 - $24.0 $4 Million - $5.39 Million	224,764	224,764 $5.39 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.